Cogstate Ltd · ASX:CGS
Cogstate — Shareholder Meeting (October 2007)
17 slides from Cogstate's shareholder meeting presentation, Oct 25, 2007
Slide 1: Annual General Meeting 25 October 2007
For personal use only Annual General Meeting 25 October 2007 www.cogstate.com
Slide 2: Martyn Myer, Chairman
For personal use only Martyn Myer Chairman www.cogstate.com
Slide 3: Financial Overview
Financial Overview For personal use only • Disappointing revenue growth for FY2007 • Cash flow loss of $1.38m for FY2007 • $1m raised via Share Purchase Plan in August 2007 – Underwriting by Directors: $0.25m • Sept 2007 qtr revenue: $0.736m – Increase of 94% on June 2007 qtr: $0.379 – Increase of 1
Slide 4: A Focus On Clinical Trials
A Focus On Clinical Trials For personal use only • Strategic business focus on clinical trials • June 2007 FY Clinical trials represented 91% of sales revenue to 30 June 2007 Clinical trial revenue up 30% (vs FY2006) • Big pharma focus new customers: Merck, AstraZeneca, Abbott Pfizer still largest c
Slide 5: Building a world class business
Building a world class business For personal use only • Full service offering to clinical trials • Expanded USA office now handling all project management oversight and customer relationship activities • DataPoint® online data monitoring tool allows real time access to study data • Implemented FDA 2
Slide 6: Expanding Market for Clinical Trials
Expanding Market for Clinical Trials For personal use only • Increased use of computerised testing in clinical trials • CogState growing revenue and market share • To date, predominantly Phase I but 2007/08 focus will be more later stage trials • Excellent growth forecasts for 2007/08 and beyond www
Slide 7: Brad O'Connor, Chief Executive Officer
For personal use only Brad O’Connor Chief Executive Officer www.cogstate.com
Slide 8: Market is large enough to build a very profitable business
CogState ClinicalTrials: building a sustainable business For personal use only Market is large enough to build a very profitable business. • Top 10 pharma companies currently conducting 187 CNS focussed trials • FY2007 CogState signed contracts to participate in 17 clinical trials, with a contract v
Slide 9: CogState has a superior product offering
CogState ClinicalTrials: building a sustainable business For personal use only CogState has a superior product offering. • Customised test battery tailored to the study design • DataPoint ® online data monitoring tool • Rapid administration allows optimum amount of data in shortest possible time • S
Slide 10: CogState is gaining market share
CogState ClinicalTrials: building a sustainable business For personal use only CogState is gaining market share. • Customers now include 5 of the 10 largest pharma companies: Pfizer (5 contracts in the last 12 months, 27 in total) Merck (2 contracts in the last 12 months) GlaxoSmithKline (2 contract
Slide 11: Sales revenue is steadily increasing
CogState ClinicalTrials: building a sustainable business For personal use only Sales revenue is steadily increasing ($2.7m for the 4 quarters ended 30 Sept 2007) www.cogstate.com
Slide 12: Increased business activity evidenced by requests for quotes
CogState ClinicalTrials: building a sustainable business For personal use only Increased business activity is evidenced by increased requests for quotes. www.cogstate.com
Slide 13: Quotes are converting into contracts
CogState ClinicalTrials: building a sustainable business For personal use only Quotes are converting into contracts. • Since 1 July 2007, CogState has signed 6 contracts for new pharma sponsored clinical studies with a combined value of A$0.83m • Contract negotiation is on-going in respect of a furt
Slide 14: Strategy for Revenue Growth
Strategy for Revenue Growth For personal use only • USA office is providing customer relationship management and building brand in the USA • Increasingly also working with European pharma companies • Will shortly announce the addition of key employee to be based in the UK Exceptional hire of experie
Slide 15: Other Products
Other Products For personal use only • CogState Health – CogState Health is a computerized memory monitoring test. It is designed to measure cognitive decline or improvement, over a period of months to years. • CogState Sport – CogState Sport is a computerized concussion test and management system f
Slide 16: Outlook
Outlook For personal use only • Continued momentum and increased sales activities • Improved half year results • Reduction in cash flow burn • Continued focus on revenue growth through Clinical Trials, both in the USA & Europe www.cogstate.com
Slide 17: Brad O'Connor, Chief Executive Officer
For personal use only Brad O’Connor Chief Executive Officer CogState Ph: 03 9664 1300 boconnor@cogstate.com www.cogstate.com